Anti-NFkB Inducing Kinase NIK antibody (ab7204) | Abcam
Structure of the Nuclear Factor κB-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation - Journal of Biological Chemistry
MAP3K kinases and kidney injury - ScienceDirect
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
PI3K inhibitors are finally coming of age | Nature Reviews Drug Discovery
NIK SMI1 | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Anti-NFkB Inducing Kinase NIK antibody - N-terminal (ab137671) | Abcam
NFkB Inducing Kinase NIK (MAP3K14) Rabbit Polyclonal Antibody – TA336951 | OriGene
NF-κB-Inducing Kinase Is Involved in the Activation of the CD28 Responsive Element through Phosphorylation of c-Rel and Regulation of Its Transactivating Activity | The Journal of Immunology
Anti-NFkB Inducing Kinase NIK antibody (ab19144) | Abcam
Nik‐related kinase is targeted for proteasomal degradation by the chaperone‐dependent ubiquitin ligase CHIP - Naito - 2020 - FEBS Letters - Wiley Online Library
IJMS | Special Issue : NF-κB and Disease
NF-κB-inducing Kinase Phosphorylates and Blocks the Degradation of Down Syndrome Candidate Region 1* - Journal of Biological Chemistry
NIK SMI1 | NF-κB Inhibitor | MedChemExpress
MAP3K kinases and kidney injury | Nefrología
The NFKB Inducing Kinase Modulates Hematopoiesis During Stress - González‐Murillo - 2015 - STEM CELLS - Wiley Online Library
Frontiers | Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity | Immunology
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status | Haematologica
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
